Russell Investments Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $553 | Buy |
60
+22
| +58% | +$203 | ﹤0.01% | 3738 |
|
|
2025
Q1 | $326 | Buy |
+38
| New | +$326 | ﹤0.01% | 3713 |
|
|
2024
Q2 | – | Sell |
-115
| Closed | -$585 | – | 3582 |
|
|
2024
Q1 | $585 | Buy |
115
+29
| +34% | +$148 | ﹤0.01% | 3188 |
|
|
2023
Q4 | $801 | Buy |
+86
| New | +$801 | ﹤0.01% | 3083 |
|
|
2023
Q2 | – | Sell |
-41,007
| Closed | -$351K | – | 3452 |
|
|
2023
Q1 | $351K | Hold |
41,007
| – | – | ﹤0.01% | 2363 |
|
|
2022
Q4 | $380K | Hold |
41,007
| – | – | ﹤0.01% | 2377 |
|
|
2022
Q3 | $423K | Hold |
41,007
| – | – | ﹤0.01% | 2308 |
|
|
2022
Q2 | $410K | Hold |
41,007
| – | – | ﹤0.01% | 2330 |
|
|
2022
Q1 | $504K | Hold |
41,007
| – | – | ﹤0.01% | 2221 |
|
|
2021
Q4 | $711K | Hold |
41,007
| – | – | ﹤0.01% | 2315 |
|
|
2021
Q3 | $736K | Sell |
41,007
-96,766
| -70% | -$1.74M | ﹤0.01% | 2322 |
|
|
2021
Q2 | $3.15M | Sell |
137,773
-120,802
| -47% | -$2.76M | 0.01% | 1643 |
|
|
2021
Q1 | $3.86M | Sell |
258,575
-86,162
| -25% | -$1.29M | 0.01% | 1492 |
|
|
2020
Q4 | $1.86M | Sell |
344,737
-148,071
| -30% | -$799K | ﹤0.01% | 1797 |
|
|
2020
Q3 | $2.24M | Buy |
492,808
+277,381
| +129% | +$1.26M | ﹤0.01% | 1611 |
|
|
2020
Q2 | $1.06M | Sell |
215,427
-26,049
| -11% | -$128K | ﹤0.01% | 2021 |
|
|
2020
Q1 | $757K | Buy |
+241,476
| New | +$757K | ﹤0.01% | 1985 |
|
|
2017
Q4 | – | Sell |
-19,196
| Closed | -$79K | – | 2952 |
|
|
2017
Q3 | $79K | Hold |
19,196
| – | – | ﹤0.01% | 2804 |
|
|
2017
Q2 | $102K | Hold |
19,196
| – | – | ﹤0.01% | 2803 |
|
|
2017
Q1 | $110K | Sell |
19,196
-6,290
| -25% | -$36K | ﹤0.01% | 2799 |
|
|
2016
Q4 | $102K | Buy |
+25,486
| New | +$102K | ﹤0.01% | 2872 |
|